- Transurban’s interim distribution per share is A$0.300.
- The company’s net income stands at A$204 million.
- The proportional EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is A$1.33 billion.
- Transurban’s total revenue is A$2.13 billion.
- The company’s shares have received 5 buy ratings, 10 hold ratings, and 2 sell ratings.
A look at Transurban Group Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
The long-term outlook for Transurban Group looks promising, according to Smartkarma’s Smart Scores. The company has received a score of 5 for growth, indicating that it is expected to see strong growth in the future. This is supported by Transurban’s core capabilities in network planning and forecasting, operations, and project development, which enable the company to expand its urban toll road networks. With a score of 3 for dividend, Transurban also offers a decent return for its shareholders.
However, the company may face some challenges in terms of value and resilience, with scores of 2 in both categories. This suggests that Transurban’s stock may not be currently undervalued and that it may not be as resilient as some of its competitors. Nevertheless, with a score of 3 for momentum, Transurban has shown positive momentum in recent times, which could bode well for its future performance. Overall, with its strong focus on urban toll road networks and operations in Australia and North America, Transurban Group seems to have a bright future ahead.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
